Five patents currently held, every record listed here
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next US patent term in the Ventus Medical, Inc. portfolio ends in May 2038. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2038
Next term end
4
Patent families
When these terms end
Each bar runs from grant to computed term end. 2009 to 2042.
US 12,599,177
Mouthpiece Assembly for an Inhalation Device including a Replaceable Substrate Component, and a Replaceable Substrate Component therefor
Jan 21, 2039
US 12,329,205
A Mouthpiece Assembly for an Inhalation Device including a Replaceable Substrate Component, and a Replaceable Substrate Component therefor
Jan 6, 2042
20162023203020372042
1 pending application: term is not computable until grant.Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2041 · High confidence
Also notable
Ends May 2038 · High confidence
Also notable
Ends Jan 2039 · High confidence
Methods, Inhalation Device, and Computer Program
US 11,850,353
The most cited patent in this portfolio, cited by 14 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2041.
A Mouthpiece and Heater Assembly for an Inhalation Device
US 10,952,467
The earliest of the three still in force, granted 2021 and renewed since. Its term ends first, in 2038.
Mouthpiece Assembly for an Inhalation Device including a Replaceable Substrate Component, and a Replaceable Substrate Component therefor
US 12,599,177
Granted 2026. Too new for citation comparison; protection runs to 2039.
Formerly held, still cited
Notable
Ends Jun 2027 · High confidence
The most cited patent in this portfolio, cited by 137 later US patents, top 5% of utility patents granted in 2009 in our data. Protection runs to 2027.
now held by Theravent, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 26, 2027The maintenance fee for Methods, Inhalation Device, and Computer Program (US 11,850,353) comes due Jun 26, 2027. Unpaid by Dec 27, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| A Mouthpiece Assembly for an Inhalation Device including a Replaceable Substrate Component, and a Replaceable Substrate Component therefor | 2 in force | to Jan 2042 |
| Aerosolizable Nicotine-Containing Formulations | 1 in force | to Dec 2042 |
| Methods, Inhalation Device, and Computer Program | 1 in force | to Apr 2041 |
| A Mouthpiece and Heater Assembly for an Inhalation Device | 1 in force | to May 2038 |
Patents held now
Soonest term end first.
Showing 1 to 5 of 5
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,952,467 | A Mouthpiece and Heater Assembly for an Inhalation Device In force · High confidence | In force | High confidence | |
| US 12,599,177 | Mouthpiece Assembly for an Inhalation Device including a Replaceable Substrate Component, and a Replaceable Substrate Component therefor In force · High confidence | In force | High confidence | |
| US 11,850,353 | Methods, Inhalation Device, and Computer Program In force · High confidence | In force | High confidence | |
| US 12,329,205 | A Mouthpiece Assembly for an Inhalation Device including a Replaceable Substrate Component, and a Replaceable Substrate Component therefor In force · High confidence | In force | High confidence | |
| US 12,588,698 | Aerosolizable Nicotine-Containing Formulations In force · High confidence | In force | High confidence |
Also on record, not counted in the 5: 1 patent in force now held by others · 23 patents ended · 1 application pending · 12 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.